Diabytes
Sun Pharma News
)
Vidhi Shanghvi Sun Pharma: Vidhi Shanghvi, the 34-year-old daughter of India’s healthcare tycoon Dilip Shanghvi, is a prominent figure in both the business and healthcare industries. As the Vice President of Sun Pharmaceutical Industries, she holds a key position within her father's vast business empire.
)
Tata Motors, Suzlon, Sun Pharma, Reliance Power, Infosys and more --check why shares of these companies are trending today.
)
Dilip Shanghvi founded Sun Pharmaceutical in 1982 in Vapi, Gujarat.
Shanghvi was born into a Gujarati family in the small village of Amreli, Gujarat.
In Kolkata, his father had a wholesale pharmaceutical business.
)
Dilip Shanghvi is the founder and managing director of Sun Pharmaceutical Industries Limited, India's most valuable listed pharma outfit.
)
The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal hit by one-time deferred tax adjustment.
)
The acquisition of 100 per cent shares of Pola Pharma Inc Japan by the company's wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing.
)
A whistleblower had last month approached Sebi with a document alleging various irregularities by the company, its promoter Shanghvi and others.
)
Pola Pharma's portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables.
)
Reliance Industries Ltd. chief Mukesh Ambani sustained India`s wealthiest position for the 10th straight year as his net worth swelled to $38 billion (nearly Rs. 2.5 trillion).
)
Following weakness in stocks, the total market capitalisation of BSE-listed companies slumped by Rs 1,38,726.77 crore to Rs 1,29,77,705 crore.
)
As per the pact, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab.
)
Shares of Sun Pharma on Monday crashed by over 13 percent after the company reported a 14 percent decline in consolidated net profit for the fourth quarter ended March.
)
Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.
)
Drug major Sun Pharmaceutical Industries has received 11 observations from the US health regulator after inspection of its Dadra facility.
)
Shares of Sun Pharma fell by 3 percent today amid reports of USFDA inspection at one of the company's plant.
)
The US health regulator has proposed to lift the import alert on Sun Pharma's Mohali (Punjab) based manufacturing plant.
)
Pharamceutical major Sun Pharma's subsidiary has invested USD 13 million (about Rs 88 crore) in the US-based scPharmaceuticals Inc, announced the company on Friday.
)
Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.
)
Pharmaceutical major Sun Pharma has informed BSE that it has completed the acquisition of the US-based eye care specialist Ocular Technologies Sarl.
)
The country's largest drug firm Sun Pharma on Wednesday said it has signed definitive agreements to acquire 85.1 percent stake in Russia-based JSC Biosintez for USD 24 million.
Loading...
 "Will Hindus get justice in Bengal's Murshidabad?")
 "DNA: Uproar over freebies in Delhi!")
 "DNA: AIMIM plans to field 2020 Delhi riots accused Shahrukh Pathan")
 "DNA: A report showing the reality of Bangladesh")
 "DNA: Power Theft Allegations Against SP MP Ziaur Rahman Barq")
 "DNA: Hot Tea Linked to Cancer Risk!")
 "DNA: Why Jordan Fears After Syria’s Coup?")
 "DNA: NSA Ajit Doval’s China Visit - Inside Story")
 "DNA: Gandhi Family Ruined My Career, says Mani Shankar Aiyar")
 "DNA: Ground Report- Tight Security Arrangements for Mahakumbh")
